With the support of many national policies, China's medical device industry has ushered in a prosperous period of development. Local governments have accelerated the development of medical devices and strive to develop this industry in the current situation. Recently, it was learned from the Hebei food and drug administration that in order to accelerate the adjustment, optimization and upgrading of the pharmaceutical industry structure in Hebei Province, strengthen independent innovation, improve and develop the modern pharmaceutical industry system, and comprehensively improve the regional development competitiveness of the pharmaceutical industry in Hebei Province, Hebei Province decided to resume the examination and approval of new pharmaceutical and medical device production and trading enterprises. The resumption of the approval has saved a lot of unnecessary trouble for local medical device manufacturers.
It is understood that this is to implement the spirit of the conference of the provincial Party committee and the provincial government on improving the development environment and ecological environment in the province, further optimize the development environment and promote the green development of the pharmaceutical industry. Hebei Province has taken effective measures to promote the establishment of comprehensive enterprises to scale and grade, and the establishment of small and medium-sized enterprises to develop in the direction of specialization. At the same time, combined with accelerating the development of pharmaceutical industry and protecting the ecological environment, develop circular economy, vigorously promote cleaner production, and promote the development of pharmaceutical industry in the direction of green and low-carbon.
In addition, while examining and approving new enterprises, all cities and departments in Hebei Province should carefully summarize the experience and achievements of the clean-up and rectification work in the previous stage. In particular, we should fully mobilize the enthusiasm and initiative of enterprise merger and reorganization, and encourage advantageous enterprises to implement cross regional and cross ownership mergers and acquisitions and joint reorganization through policy guidance and active services; Promote the concentration of resources such as varieties, technologies and channels to advantageous enterprises; Improve and extend the industrial chain. By the end of the year, we will strive to make breakthroughs in solving the problems of many, small, scattered and low, promote the expansion, strengthening and specialization of the pharmaceutical industry, and enhance the comprehensive competitiveness of the pharmaceutical industry.
